Abstract:The development of safe and effective delivery systems is critical for the clinical applications of siRNA-based therapeutics. Polymer-based vectors have garnered significant attention owing to their structural flexibility and functional tunability. Polyethyleneimine (PEI) has been extensively studied for nucleic acid delivery; nevertheless, its high cytotoxicity has posed challenges for clinical applications. In this study, we have reported poly(glycidyl amine) (PGAm), a linear PEI analogue, demonstrating remarkable siRNA delivery efficacy and improved biocompatibility. By introducing three aromatic moieties (tyrosine, p-hydroxybenzenepropanoic acid, and phenylalanine) at varying ratios to further modify PGAms, we successfully constructed a library comprising 36 PGAm-based carriers. In vitro evaluations revealed that PGAm-based carriers exhibited significantly enhanced biocompatibility and reduced non-specific protein absorption in comparison to PEI25k. Among them, 10 modified PGAms achieved a knockdown of target gene expressions exceeding 80%, and 26 modified PGAms maintained over 70% cell viability when utilized for the in vitro delivery of siRNA to HeLa cells. Explorations into the structure-activity relationship of PGAm-based polyplex nanoparticles (NPs) indicated that the siRNA delivery efficacy of NPs depended on factors such as the molecular weight of PGAm precursors, the type of modifying moieties, and the modification ratio. Furthermore, it was demonstrated that two top-performing NPs, namely 2T100/siLuc and 2A50/siLuc, exhibited potent silencing of target genes in tumors following i.v. injection into mice bearing HeLa-Luc xenografts. The in vivo efficacy of the selected NPs was further validated by a remarkable anti-cancer effect when employed for the delivery of siRNA targeting polo-like kinase 1 (siPLK1) to mice with PC-3 xenograft tumors. The intravenous administration of NPs resulted in a substantial inhibition of tumor growth without significant toxicity. These findings demonstrate the feasibility of employing PGAm in siRNA delivery and provide valuable insights for the development of efficient siRNA carriers based on PGAm.

High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics.

Polycation-functionalized nanoporous silicon particles for gene silencing on breast cancer cells

The Ph-Triggered Triblock Nanocarrier Enabled Highly Efficient Sirna Delivery for Cancer Therapy

Preparation and Characterization of Polymeric Nanoparticles for Sirna Delivery to Down-Regulate the Expressions of Exogenous and Endogenous Target Genes.

Porous Silicon Microparticles for Delivery of Sirna Therapeutics

Pegylated Carboxymethyl Chitosan/Calcium Phosphate Hybrid Anionic Nanoparticles Mediated Htert Sirna Delivery for Anticancer Therapy

Multi-step Encapsulation of Chemotherapy and Gene Silencing Agents in Functionalized Mesoporous Silica Nanoparticles.

Effective Gene Silencing Mediated by Polypeptide Nanoparticles LAH4-L1-siMDR1 in Multi-Drug Resistant Human Breast Cancer.

Systemic Delivery of Sirna with Cationic Lipid Assisted PEG-PLA Nanoparticles for Cancer Therapy.

Cyclodextrin and Polyethylenimine Functionalized Mesoporous Silica Nanoparticles for Delivery of Sirna Cancer Therapeutics.

Enhanced endosomal escape of siRNA-incorporating hybrid nanoparticles from calcium phosphate and PEG-block charge-conversional polymer for efficient gene knockdown with negligible cytotoxicity

Hybrid Lipid–polymer Nanoparticles for Sustained Sirna Delivery and Gene Silencing

Monodispersed brush-like conjugated polyelectrolyte nanoparticles with efficient and visualized siRNA delivery for gene silencing.

SiRNA-phospholipid Conjugates for Gene and Drug Delivery in Cancer Treatment.

Systemic Sirna Delivery to a Spontaneous Pancreatic Tumor Model in Transgenic Mice by PEGylated Calcium Phosphate Hybrid Micelles.

Novel aromatic moieties-modified poly(glycidyl amine)s with potent siRNA delivery and cancer treatment effect

Intracellular cleavable poly(2-dimethylaminoethyl methacrylate) functionalized mesoporous silica nanoparticles for efficient siRNA delivery in vitro and in vivo.

Delivery Pathway Regulation of 3′,3″-Bis-peptide-sirna Conjugate Via Nanocarrier Architecture Engineering

Efficient Systemic Delivery Of Sirna By Using High-Density Lipoprotein-Mimicking Peptide Lipid Nanoparticles

Bioreducible, Arginine-Rich Polydisulfide-Based Sirna Nanocomplexes with Excellent Tumor Penetration for Efficient Gene Silencing.

Stimuli-responsive Hybrid Nanocarriers Developed by Controllable Integration of Hyperbranched PEI with Mesoporous Silica Nanoparticles for Sustained Intracellular Sirna Delivery.